Premium
Identification of a thermal degradation product of CUMYL‐PEGACLONE and its detection in biological samples
Author(s) -
Nash Christine,
Glowacki Linda,
Gerostamoulos Dimitri,
Pigou Paul,
Scott Timothy,
Kostakis Chris
Publication year - 2019
Publication title -
drug testing and analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 54
eISSN - 1942-7611
pISSN - 1942-7603
DOI - 10.1002/dta.2685
Subject(s) - synthetic cannabinoids , degradation (telecommunications) , chemistry , thermal stability , chromatography , residue (chemistry) , cannabinoid , organic chemistry , biochemistry , computer science , telecommunications , receptor
The structural diversity of synthetic cannabinoids makes it a challenging task to have a comprehensive screening method for this class of drugs. The difficulty is increased by the fact that some synthetic cannabinoids undergo thermal decomposition during common routes of administration, such as smoking or vaping. CUMYL‐PEGACLONE is a relatively new synthetic cannabinoid which has a structural variant from most other synthetic cannabinoids: a γ‐carbolinone core. To investigate its thermal stability, CUMYL‐PEGACLONE was heated in an oven at temperatures ranging from 200 to 350 o C, and a major thermal degradation product, N‐pentyl‐γ‐carbolinone, was subsequently identified. Unlike some other synthetic cannabinoids, the thermal degradation product of CUMYL‐PEGACLONE is not one of its known metabolites, nor were any known metabolites detected during the thermal stability experiments. The degradation product was formed in significant amounts at temperatures above 250°C, and has been detected (along with CUMYL‐PEGACLONE) in case samples, including post‐mortem blood and urine, and residue found at a scene.